Account
Insider Insights
06.10.2023
Germany’s Health Ministry Shifts Focus to Di...

Germany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...

Read more
Webinar
06.10.2023
Orphan Medicine Market Access in Europe

Webinar: Our experts discuss Orphan medicine market access in Europe including the impact of EU HTA ...

Read more
Articles
07.09.2023
Prescription Price Puzzles: The Sky-High Cost of O...

This article explores the significant disparities between the US and Europe regarding orphan drugs a...

Read more
Insider Insights
17.08.2023
Managed entry agreements: €195m saved by the Ita...

MEAs resulted in 195.2 million of savings for the Italian healthcare system, according to AIFA’s M...

Read more
Articles
21.06.2023
What are the current unmet needs in Oncology?

We explore the innovative assessment criteria for novel cancer therapies and the unmet needs in onco...

Read more
News
07.06.2023
PMA Insights: Week 23

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
News
17.05.2023
PMA Insights: Week 20 SPECIAL EDITION – ISPO...

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...

Read more
Insider Insights
05.05.2023
HAS issues favorable reimbursement opinion

This is the first time that HAS is issuing a favorable opinion for the reimbursement of a technology...

Read more
Insider Insights
04.05.2023
NICE collaborates with international partner agenc...

UK, Canada and United States join forces to streamline process and increase transparency for confide...

Read more
Articles
02.05.2023
Unveiling the Progress of a Coordinated HTA Networ...

We explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.